An open-label, long term extension study to assess the safety andefficacy of BI 655130 treatment in patients with GeneralizedPustular Psoriasis (GPP)
Randomized Evaluation of dabigatran etexilate Compared to warfarIn in pulmonaRy vein ablation: assessment of an uninterrupted periproCedUral alntIcoagulation sTrategy (The RE-CIRCUIT Trial) - RE-CIRCUIT
100 项与 Boehringer Ingelheim France SASU 相关的临床结果
0 项与 Boehringer Ingelheim France SASU 相关的专利（医药）
100 项与 Boehringer Ingelheim France SASU 相关的药物交易
100 项与 Boehringer Ingelheim France SASU 相关的转化医学
